BSECompany Update6d ago · 27 Oct 2026, 02:53 pm
Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company
Fischer Medical Ventures Ltd · 524743
✦ AI SummaryMgmt Change
Fischer Medical Ventures Ltd has appointed Mr. Chan Sing En as an Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., a material wholly owned subsidiary company, with effect from October 27, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Ltd - 524743 - Appointment Of Independent Director On The Board Of Material Wholly Owned Subsidiary Company
Attachments (1)
📄pdf
Download →
84c90a9d-beab-4d28-82d3-795afd7d5887.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
October 27, 2026
To To
BSE Limited National Stock Exchange of India Ltd.
Corporate Relationship Department Exchange Plaza, 5tll floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001 Mumbai - 400 051
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir/ Madam,
Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Pursuant to Regulation 24(1) read with Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we wish to inform you that Mr. Chan Sing En has been appointed as an
Independent Director on the Board of Directors of FMV Global Innovations Pte. Ltd., Singapore, an unlisted
material wholly owned subsidiary of the Company, with effect from 27.10.2026 (Today).
Details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 are enclosed herewith as
Annexure-1.
The above appointment is in accordance with the applicable provisions of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
This is submitted for your information and records.
Thanking you,
Yours Truly,
For FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY AND COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
Annexure-1
Details under Regulation 30 of the Listing Regulations read with SEBI Circular No.
EBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
Name MR. CHAN SING EN
DIN 11300541
Reason for change viz. Appointment of Mr. Chan Sing En (DIN: 11300541), as a common
appointment, reappointment, Independent Director of the material wholly owned subsidiary of the
resignation, removal, death Company- FMV Global Innovations Pte. Ltd., Singapore.
or otherwise
Date of appointment/re- 27-10-2026
appointment/cessation (as
applicable) & term of
appointment/reappointment
Term of As per the resolution passed in accordance with the laws of Singapore.
appointment/reappointment
Brief profile (in case of Mr. Chan Sing En is a dynamic investment professional with over three
appointment) decades of experience spanning Southeast Asia and Australia. He has built
a distinguished career in private equity, corporate finance, and operational
turnarounds, consistently driving growth and value creation across diverse
industries. His deep understanding of financial structuring and market
strategy has enabled numerous successful business revitalizations and
investor partnerships.
As Principal and Director of SovCapital Pte Ltd, Singapore, Mr. Chan leads
strategic investment and restructuring initiatives for both private and public
companies. He specializes in reverse takeovers, capital raising, and pre-IPO
consultancy, offering seasoned guidance to founders and executives. His
leadership is marked by a hands-on approach that combines strategic
foresight with operational precision.
In addition, Mr. Chan serves on the advisory board of FTAG Investment
Bank in Malaysia, contributing to high-profile corporate finance transactions
and cross-border deals, including the NASDAQ listing of a global supercar
brand. A graduate of Pepperdine University, USA, with a degree in Business
Administration, he continues to bring financial acumen, boardroom
experience, and visionary leadership to every engagement.
Disclosure of relationships Mr. Chan Sing En is not related to any of the Directors of the Company.
between Directors
Information as required Mr. Chan Sing En is not debarred from holding the office of Director by
pursuant to BSE Circular ref. virtue of any SEBI Order or any such authority
no. LIST/COMP/14/2018-19
and NSE ref. no.
NSE/ML/2018/24 dated June
20, 2018.
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006